OPEN ACCESS: All GlaxoSmithKline slashes cost of AIDS drug: GlaxoSmithKline is to reduce the cost of its antiretroviral drug Combivir (zidovudine and lamivudine) by almost half to $0.90 (£0.57; a0.82) a day in 63 developing countries. The company's move comes after pressure from the company's institutional investors to make access to AIDS drugs easier.
US sugar industry pressurises …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: A prescription for improving antibiotic prescribing in primary care
Published 15 February 2012
Re: Migrant healthcare: public health versus politics
Published 15 February 2012
Re: Dosing of oral penicillins in children: is big child=half an adult, small child=half a big child, baby=half a small child still the best we can do?
Published 15 February 2012
Re: Scientists are to investigate “three parent IVF” for preventing mitochondrial diseases
Published 15 February 2012
Re: A commitment to protect health and save lives
Published 15 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012